PAVmed
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-0.16-0.87N/A
Price/Sales ratio
2.010.360.24
Earnings per Share (EPS)
$-2.56$-0.48N/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-78.52-31.74-15.83-3.23-1.19-2.27-2.92-3.78-0.42-0.46-0.39-1.19
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A381.37113.4112.1592.17N/A
Price/Book Value ratio
54.2188.96-280.53-10.82-9.25-9.4753.033.09-4.41-0.55-3.58-9.25
Price/Cash Flow ratio
-714.97-45.12-20.09-4.66-2.43-2.71-4.58-4.69-0.60-0.57-0.48-2.43
Price/Free Cash Flow ratio
-714.97-45.12-19.99-4.66-2.43-2.70-4.57-4.53-0.58-0.56-0.47-2.43
Price/Earnings Growth ratio
N/A-0.21-0.08-0.04-0.120.06-0.090.36-0.000.010.00-0.12
Dividend Yield
N/AN/AN/AN/A0.03%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A-17%-858.62%-161.82%-858.35%N/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A-10878.6%-24118.56%-2805.66%-24072.67%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A-11225.19%-27384.08%-3232.58%-27384.08%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A-10069.4%-26868.43%-2617.25%-23602.91%N/A
Effective Tax Rate
23.04%100%N/A-9.23%1.12%7.74%4.34%10.29%1.88%N/AN/A7.74%
Return on Assets
-65.16%-146.33%-649.21%-580.55%-211.48%-220.03%-173.57%-57.88%-187.65%-193.77%-164.84%-211.48%
Return On Equity
-69.04%-280.25%1771.05%334.20%776.30%416.63%-1810.60%-81.64%1046.31%119.21%-529.84%416.63%
Return on Capital Employed
-53.12%-280.25%1771.05%888.64%426.59%308.21%13497.68%-68.48%-711.47%326.69%-710.12%308.21%
Liquidity Ratios
Current Ratio
N/AN/A0.620.630.770.550.94N/AN/AN/A1.060.77
Quick Ratio
17.821.330.620.630.770.550.9010.311.050.440.960.77
Cash ratio
17.751.320.490.600.740.520.8610.220.960.360.960.74
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A14616.459.0816.45N/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A13.56K2.90K26.3530.6426.36N/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A3.04K42.8139.7230.42N/A
Days of Payables Outstanding
N/AN/A91.36K44.37K64.82K60.36K47.06K2.05K273.09101.54273.1660.36K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A990.80-230.27-61.81-250.20N/A
Debt Ratios
Debt Ratio
N/AN/AN/A1.180.931.120.77N/A0.621.330.791.12
Debt Equity Ratio
N/AN/AN/A-0.68-3.41-2.128.04N/A-3.47-0.82-4.44-2.12
Long-term Debt to Capitalization
N/AN/AN/A-2.15N/AN/A0.13N/AN/AN/A-0.23N/A
Total Debt to Capitalization
N/AN/AN/A-2.151.411.880.88N/A1.40-4.581.351.88
Interest Coverage Ratio
N/AN/AN/A-11.08-4.41-437.60-440.58N/AN/AN/A-71.40-437.60
Cash Flow to Debt Ratio
N/AN/AN/A-3.39-1.11-1.64-1.43N/A-2.10-1.17-1.93-1.64
Company Equity Multiplier
1.051.91-2.72-0.57-3.67-1.8910.431.41-5.57-0.61-5.57-1.89
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A-81.18-188.28-21.22-188.28N/A
Free Cash Flow / Operating Cash Flow Ratio
111.001.001.001.001.001.031.021.001.021.00
Cash Flow Coverage Ratio
N/AN/AN/A-3.39-1.11-1.64-1.43N/A-2.10-1.17-1.93-1.64
Short Term Coverage Ratio
N/AN/AN/AN/A-1.11-1.64-1.46N/A-2.10-1.17-2.04-1.64
Dividend Payout Ratio
N/AN/AN/AN/A-0.03%N/AN/AN/AN/AN/AN/A-0.03%